543500 EVOQ

Evoq Remedies Share Price

 

 

Start SIP in EVOQ

Start SIP

Performance

  • Low
  • ₹3
  • High
  • ₹4
  • 52 Week Low
  • ₹2
  • 52 Week High
  • ₹8
  • Open Price₹3
  • Previous Close₹3
  • Volume20,000

Investment Returns

  • Over 1 Month + 9.03%
  • Over 3 Month -10.26%
  • Over 6 Month -33.21%
  • Over 1 Year -57.21%

Smart Investing Starts Here Start SIP with Evoq Remedies for Steady Growth!

Invest Now

Evoq Remedies Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 98.8
  • PEG Ratio
  • -
  • Market Cap Cr
  • 9
  • P/B Ratio
  • 0.2
  • Average True Range
  • 0.21
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.1
  • RSI
  • 47.7
  • MFI
  • 55.91

Evoq Remedies Financials

Evoq Remedies Technicals

EMA & SMA

Current Price
₹3.50
+ 0.16 (4.79%)
pointer
  • Bearish Moving Average 8
  • Bullish Moving Average 8
  • 20 Day
  • ₹3.37
  • 50 Day
  • ₹3.63
  • 100 Day
  • ₹3.92
  • 200 Day
  • ₹4.61

Resistance and Support

3.24 Pivot Speed
  • R3 3.74
  • R2 3.54
  • R1 3.44
  • S1 3.14
  • S2 2.94
  • S3 2.84

Ratings

Master Rating

EPS Strenth

N/A

Price Strength

Buyer Demand

Group Rank

Evoq Remedies has an operating revenue of Rs. 41.32 Cr. on a trailing 12-month basis. An annual revenue growth of 125% is outstanding, Pre-tax margin of 1% needs improvement, ROE of 0% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 27 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 84 indicates it belongs to a poor industry group of Medical-Ethical Drugs and a Master Score of E is the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Evoq Remedies Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-10-10 Quarterly Results
2025-05-06 Preferential issue of shares
2025-04-29 Others Rs.0.00 to consider 1. Raising of funds upto Rs. 99.00 Crores by way of issue of Warrants. 2. Issuance of Equity shares other than cash through swap of shares. 3. Other business matters. (Revised)
2025-04-10 Audited Results
2024-05-27 Audited Results

Evoq Remedies F&O

Evoq Remedies Shareholding Pattern

11.21%
83.89%
4.9%

About Evoq Remedies

  • NSE Symbol
  • EVOQ
  • BSE Symbol
  • 543500
  • Managing Director
  • Mr. Bhumishth Patel
  • ISIN
  • INE0JVD01011

Similar Stocks to Evoq Remedies

Evoq Remedies FAQs

Evoq Remedies share price is ₹3 As on 02 January, 2026 | 10:15

The Market Cap of Evoq Remedies is ₹8.7 Cr As on 02 January, 2026 | 10:15

The P/E ratio of Evoq Remedies is 98.8 As on 02 January, 2026 | 10:15

The PB ratio of Evoq Remedies is 0.2 As on 02 January, 2026 | 10:15

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23